Stockreport

Assessing Palvella Therapeutics' Valuation After Its Rare Disease Momentum-Driven Surge in 2024 [Yahoo! Finance]

Palvella Therapeutics, Inc.  (PVLA) 
PDF See our latest analysis for Palvella Therapeutics. The latest move takes Palvella's share price to $99.73, capping a powerful 90 day share price return of 71.24 perce [Read more]